 |
JOURNAL TOOLS |
| Opzioni di pubblicazione |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW CHRONIC OBSTRUCTIVE PULMONARY DISEASE Free access
Minerva Medica 2022 June;113(3):449-59
DOI: 10.23736/S0026-4806.22.08001-6
Copyright © 2022 EDIZIONI MINERVA MEDICA
lingua: Inglese
Treatable traits in COPD patients
Francesco NUCERA 1, Andrea BIANCO 2, Teresa DAVID 3, Ilaria SALVATO 1, Ian M. ADCOCK 4, Gaetano CARAMORI 1 ✉
1 Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Messina, Italy; 2 Department of Translational Medical Sciences, L. Vanvitelli University of Campania, Naples, Italy; 3 Unit of Emergency Medicine, G. Martino University Hospital, Messina, Italy; 4 Section of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK
There is no justification for a therapeutic nihilism in clinical practice because current management (pharmacological and non-pharmacological) of the patients with chronic obstructive pulmonary disease according to treatable traits is effective in decreasing their respiratory symptoms, increasing their exercise tolerance and capacity, improving their quality of life, preventing (and treating) many of their exacerbations and decreasing their mortality.
KEY WORDS: Pulmonary disease, chronic obstructive; Smoking cessation; SARS-CoV-2; Glucocorticoids; Bronchodilator agents